Advertisement
Mr. Masanotti, 53, was most recently managing director and global head ofBusiness Process Sourcing at Deutsche Bank, where he was responsible for theoffshore and onshore labor productivity and efficiency for the investmentbanking platform.
Advertisement
Previously, he was chief operating officer and executive vice president ofOfficeTiger LLC, a judgment-based knowledge process outsourcing firm,servicing major investment banks and Fortune 500 corporations. Prior to that,he was chief operating officer of Geller & Company, a privately held financeand accounting outsourcing firm. He also held executive positions at BaltimoreTechnologies Inc., a Dublin, Ireland-based e-security solutions provider, andat International Telecommunication Data Systems Inc., a leading billing andcustomer care solutions provider to the wireless telecommunications industry.
Mr. Masanotti began his career at Kleban & Samor P.C., a Connecticut lawfirm, where he was managing partner. He is a cum laude graduate of TempleUniversity of Law in Philadelphia and holds a bachelor's degree in economics(magna cum laude) from the University of Connecticut-Storrs.
According to MedQuist Chairman of the Board Robert Aquilina, "Peter bringsa wealth of background in leading global operational teams in both thetechnology and labor sectors, along with strategic product management andcustomer-focused service development. We are pleased to have an executive ofhis caliber at the helm of MedQuist during this exciting time."
Mr. Aquilina confirmed that Mark Ivie, who had been serving as MedQuist'sinterim president and CEO, will continue to serve as chief technology officer.He added, "The board of directors is very appreciative of the work Mark andthe entire senior management team have completed over the past year to leadMedQuist into a new era."
Mr. Masanotti commented, "I believe MedQuist is poised to grow andcontinue to lead the market for clinical documentation. I have been impressedwith the board and the management team during our interactions to date, andlook forward to working with the team to drive the Company's continuedsuccess."
MedQuist is the largest Medical Transcription Service Organization (MTSO)in the world, and a leader in technology-enabled clinical documentationworkflow. MedQuist's enterprise solutions -- including mobile voice capturedevices, speech recognition, Web-based workflow platforms, and global networkof medical editors -- help healthcare facilities improve patient care,increase physician satisfaction, and lower operational costs. For moreinformation, please visit www.medquist.com.
"Safe Harbor" Statement under the U.S. Private Securities LitigationReform Act of 1995: Statements in this press release regarding MedQuist'sbusiness that are not historical facts are "forward-looking statements" thatinvolve risks and uncertainties. Actual outcomes and results may differmaterially from what is expressed or forecasted in forward-looking statements.As a result, forward-looking statements speak only as of the date they weremade, and the Company undertakes no obligation to publicly update or reviseany forward-looking statements, whether as a result of new information, futureevents or otherwise.
SOURCE MedQuist Inc.
